To explore the efficacy of imipenem combined with Yiyuan Qingfei decoction in severe pneumonia and its effect on serum leukotrienes (LT)B4, soluble urokinase-type plasminogen activator receptor (suPAR)and pentraxins (PTX)3.
A total of 108 patients with severe pneumonia in our hospital from July 2021 to July 2023 were selected and randomly divided into the control group (imipenem+ambroxol) and the study group (imipenem+Yiyuan Qingfei decoction), with 54 cases in each group. All patients were treated for 2 weeks. The curative effects, traditional Chinese medicine (TCM) syndrome scores, inflammatory indicators, changes in LTB4, suPAR and PTX3 levels of the two groups were compared, and the occurrence of adverse reactions during the treatment course was recorded.
After treatment, the clinical efficacy of the study group was higher than that of the control group (94.44% vs.79.63%, P<0.05), and the levels of TCM syndrome score, C-reactive protein, tumor necrosis factor-α, interleukin-6, interleukin-10, LTB4, suPAR, and PTX3 were all lower than those of the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P>0.05).
Imipenem combined with Yiyuan Qingfei decoction has a significant therapeutic effect on severe pneumonia and can effectively improve the levels of serum LTB4, suPAR and PTX3. It is worthy of promotion.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |